These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8728831)

  • 1. Policosanol inhibits cholesterol biosynthesis and enhances low density lipoprotein processing in cultured human fibroblasts.
    Menendez R; Fernandez SI; Del Rio A; Gonzalez RM; Fraga V; Amor AM; Mas RM
    Biol Res; 1994; 27(3-4):199-203. PubMed ID: 8728831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol-lowering effects of policosanol in rabbits.
    Arruzazabala ML; Carbajal D; Mas R; Molina V; Valdes S; Laguna A
    Biol Res; 1994; 27(3-4):205-8. PubMed ID: 8728832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats.
    Menendez R; Amor AM; Gonzalez RM; Fraga V; Mas R
    Biol Res; 1996; 29(2):253-7. PubMed ID: 9278716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
    Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase.
    Singh DK; Li L; Porter TD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1020-6. PubMed ID: 16714400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia.
    Francini-Pesenti F; Beltramolli D; Dall'acqua S; Brocadello F
    Phytother Res; 2008 Mar; 22(3):318-22. PubMed ID: 18167048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.
    Gouni-Berthold I; Berthold HK
    Am Heart J; 2002 Feb; 143(2):356-65. PubMed ID: 11835043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ezetimibe-policosanol combination has the potential to be an OTC agent that could dramatically lower LDL cholesterol without side effects.
    McCarty MF
    Med Hypotheses; 2005; 64(3):636-45. PubMed ID: 15617880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
    Cubeddu LX; Cubeddu RJ; Heimowitz T; Restrepo B; Lamas GA; Weinberg GB
    Am Heart J; 2006 Nov; 152(5):982.e1-5. PubMed ID: 17070175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policosanol: a new treatment for cardiovascular disease?
    Janikula M
    Altern Med Rev; 2002 Jun; 7(3):203-17. PubMed ID: 12126462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
    Mirkin A; Mas R; Martinto M; Boccanera R; Robertis A; Poudes R; Fuster A; Lastreto E; Yañez M; Irico G; McCook B; Farré A
    Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bezafibrate on biosynthesis of cholesterol and on degradation of native and acetylated low-density lipoproteins in incubated human monocytes.
    Cosentini R; Blasi F; Sommariva D; Tosi C; Fasoli A
    Drugs Exp Clin Res; 1992; 18(6):245-50. PubMed ID: 1478164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policosanol has no antioxidant activity in human low-density lipoprotein but increases excretion of bile acids in hamsters.
    Ng CH; Leung KY; Huang Y; Chen ZY
    J Agric Food Chem; 2005 Aug; 53(16):6289-93. PubMed ID: 16076108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S; Gamez R; Mas R; Goicochea E
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts.
    Menéndez R; Amor AM; Rodeiro I; González RM; González PC; Alfonso JL; Más R
    Arch Med Res; 2001; 32(1):8-12. PubMed ID: 11282173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation.
    Chait A; Bierman EL; Albers JJ
    J Clin Invest; 1979 Nov; 64(5):1309-19. PubMed ID: 227931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N; Illnait J; Más R; Fernández L; Fernández J; Castaño G
    Int J Clin Pharmacol Res; 1999; 19(4):117-27. PubMed ID: 10939029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of policosanol inhibits in vitro copper ion-induced rat lipoprotein peroxidation.
    Menéndez R; Fraga V; Amor AM; González RM; Más R
    Physiol Behav; 1999 Aug; 67(1):1-7. PubMed ID: 10463622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of policosanol on arterial blood pressure in rats. Study of the pharmacological interaction with nifedipine and propranolol.
    Molina Cuevas V; Arruzazabala ML; Carbajal Quintana D; Más Ferreiro R; Valdés García S
    Arch Med Res; 1998; 29(1):21-4. PubMed ID: 9556918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.